Dr Michelle Perugini is an entrepreneur, academic and an internationally renowned expert in health, medical research, advanced analytics, and cognitive AI.
Michelle spent the first 13 years of her career in health and medical research, specialising in predictive genetics and translational medicine. Michelle led large complex research projects that translated genetic mutation analysis (bioinformatics) to clinical treatments for cancer patients. She was also the pioneer of new methods in proteomics that now drive drug discovery.
In 2007 Michelle co-founded the innovative start-up ISD Analytics where she led the research and development, and commercialisation, of its award¬ winning human-population behaviour predictive analytics software product Simulait. ISD Analytics was acquired by Ernst & Young (EY) in 2015 and became one of EY’s global suite of analytics products. Michelle is now working with and mentoring various innovative technology start-ups, and is a co-founder of Presagen and Life Whisperer.
Life Whisperer uses artificial intelligence (AI) to better identify healthy embryos for IVF, and to ultimately improve outcomes for couples wanting to have children.
Presagen's unique AI platform allows rapid development and delivery of cloud-based products for automating human behavior, and image-based medical diagnostics.
Speaker at Advancing Analytics 2018